Journal article
Anaerobic pleuropulmonary infection
Current opinion in infectious diseases, v 14(2), pp 187-191
Apr 2001
PMID: 11979131
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Obligate anaerobes are the predominant constituents of normal oropharyngeal flora and produce pleuropulmonary infection in patients who are prone to aspirate. Obtaining material from these patients for culture from the site of infection that is uncontaminated by normal flora is problematic. In-vitro cultivation of obligate anaerobes requires rigorous anaerobic techniques and susceptibility testing of obligate anaerobes is not standardized in many clinical microbiology laboratories. Few clinical trials of drugs have been done in patients with laboratory documented or putative anaerobic pulmonary infection. For these reasons the diagnosis and therapy of anaerobic pulmonary infection are frequently empirical and guided by published studies of in-vitro activity against collected clinical isolates. Several new drugs that have in-vitro activity against obligate anaerobes have recently become available for empirical treatment of pneumonia.
Metrics
Details
- Title
- Anaerobic pleuropulmonary infection
- Creators
- Matthew Levison - Hahnemann University Hospital
- Publication Details
- Current opinion in infectious diseases, v 14(2), pp 187-191
- Publisher
- Lippincott Williams & Wilkins, Inc
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Medicine (Graduate)
- Web of Science ID
- WOS:000167761600013
- Scopus ID
- 2-s2.0-0035077401
- Other Identifier
- 991019168258804721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Web of Science research areas
- Infectious Diseases